Cresset Asset Management’s Pulmonx LUNG Stock Holding History

Cresset Asset Management’s Portfolio LUNG Stock Details LUNG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-10,635	Closed	-$139K	–	1907
2023 Q2	$139K	Buy	+10,635	New	+$130K	﹤0.01%	1784

Other funds holding LUNG

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

KXA

KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Cresset Asset Management's LUNG Position: Q3 2023 in Review

Cresset Asset Management sold out of Pulmonx (LUNG) in Q3 2023, closing a stake of 10,635 shares — an estimated $139K sold.

Cresset Asset Management first reported a position in LUNG in Q2 2023 and held it in 1 quarter. The position peaked at $139K in Q2 2023. 117 funds tracked by Wall St. Rank hold LUNG as of Q3 2023.

Cresset Asset Management reported no remaining Pulmonx position as of Q3 2023 after selling out during the quarter.
Cresset Asset Management sold 10,635 Pulmonx shares in Q3 2023, an estimated $139K.
Cresset Asset Management first reported a position in Pulmonx in Q2 2023 and held it in 1 quarter.
Cresset Asset Management's Pulmonx position peaked at $139K in Q2 2023.
117 funds tracked by Wall St. Rank held Pulmonx as of Q3 2023.

Based on Cresset Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.